Kenneth A. Jacobson
Affiliations: | Molecular Recognition | NIDDK, NIH, Bethesda, MD, United States |
Area:
GPCRs, adenosine, P2 receptorsWebsite:
https://www.niddk.nih.gov/about-niddk/staff-directory/biography/jacobson-kennethGoogle:
"Kenneth A Jacobson"Mean distance: 18.3 (cluster 46) | S | N | B | C | P |
Cross-listing: Neurotree
Parents
Sign in to add mentorMurray Goodman | grad student | 1981 | UCSD | |
(Monodisperse peptide conjugates of catecholamines : new congeners and carrier molecules) | ||||
Abraham Patchornik | post-doc | 1981-1983 | Weizmann Institute |
Children
Sign in to add traineeCollaborators
Sign in to add collaborator
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Toti KS, Verma R, McGonnigle MJ, et al. (2022) Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2-naphtho[1,2-][1,4]diazepine-2,4(3)-diones as P2X4 Receptor Antagonists. Journal of Medicinal Chemistry |
Jung YH, Shah Q, Lewicki SA, et al. (2022) Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 75: 128981 |
Fisher CL, Fallot LB, Wan TC, et al. (2022) Characterization of Dual-Acting A Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα and Gα Isoprotein Activation. Acs Pharmacology & Translational Science. 5: 625-641 |
Shiriaeva A, Park D, Kim G, et al. (2022) GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A Adenosine Receptor. Journal of Medicinal Chemistry |
Puhl AC, Gao ZG, Jacobson KA, et al. (2022) Machine Learning for Discovery of New ADORA Modulators. Frontiers in Pharmacology. 13: 920643 |
Jacobson KA, Kim HS, Ravi G, et al. (2022) Engineering of A Adenosine and P2Y Nucleotide Receptors and Their Ligands. Drug Development Research. 58: 330-339 |
Kim YC, Karton Y, Ji XD, et al. (2022) Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A Adenosine Receptors. Drug Development Research. 47: 178-188 |
Toti KS, Campbell RG, Lee H, et al. (2022) Fluorescent A and A adenosine receptor antagonists as flow cytometry probes. Purinergic Signalling |
Merighi S, Borea PA, Varani K, et al. (2022) Pathophysiological Role and Medicinal Chemistry of A Adenosine Receptor Antagonists in Alzheimer's Disease. Molecules (Basel, Switzerland). 27 |
Suresh RR, Gao ZG, Salmaso V, et al. (2022) Selective A Adenosine Receptor Antagonist Radioligand for Human and Rodent Species. Acs Medicinal Chemistry Letters. 13: 623-631 |